The Trump administration signaled Medicare drug price negotiations under the Inflation Reduction Act (IRA) signed in 2022 by ...
Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...
Three Democratic senators want answers from Health and Human Services Secretary Robert F. Kennedy Jr. about his private meetings with drugmakers alongside President Trump at his Mar-a-Lago club in ...
Whether or not the Trump administration will ... and the administration to protect Medicare’s ability to negotiate lower prescription drug prices.
New Jersey's powerful pharmaceutical industry, already under pressure to rein in prices, is facing new headwinds from a Trump ...
US taxpayers spent an estimated $6 billion researching, developing, and implementing new blockbuster weight-loss drugs, ...
Trump has so far not targeted any of Biden's signature healthcare policies, including Medicare drug pricing negotiation powers, the $35 monthly cap on insulin copays, and the $2,000 annual cap on ...
Trump has reportedly set up a “Drug Pricing and Innovation ... He had pledged to allow the federal programme Medicare to use its bargaining power to negotiate prices, a move that would bring ...
Trump is a threat to these bedrock programs ... To pay for the program, Harris plans to expand Medicare drug price negotiations, increase the discounts drug manufacturers cover for certain ...
has said it will announce the next 15 drugs in scope for the second round of the Medicare negotiation programme by 1st February next year, with the negotiated prices due to be announced by 30th ...
One of the last acts by the Trump administration before the House ... mainly on allowing the federal government to negotiate drug prices and index pricing that references the cost of drugs in ...
A Boston College Center for Retirement Research report looks at the financial implications for Medicare of Alzheimer's drug Aduhelm The recent controversy over Alzheimer’s treatment Aduhelm—criticized ...